Cannara Biotech (TSX:LOVE) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. This is a 25 percent increase over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $31.828 million which beat the analyst consensus estimate of $31.233 million by 1.90 percent. This is a 16.45 percent increase over sales of $27.333 million the same period last year.